Eurofins-Cerep SA
Research Eurofins-Cerep SA (ALECR) on Bullrun: market cap EUR 91.30M, P/E 11.8. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerALECR
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencyEUR
- Market capEUR 91.30M
- P/E11.8
- Financial periodFY2025
- RevenueEUR 40.98M
- Revenue growth1.3%
- Net incomeEUR 4.78M
- Gross margin53.5%
Valuation Snapshot
latest market cap is EUR 91.30M; P/E is 11.8.
Peer valuation comparison
Latest P/E is 11.75x versus a Healthcare sector median of 24.61x (52.2% below).
Latest P/E is 11.75x versus a France median of 14.07x (16.5% below).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 40.98M | EUR 4.78M | n/a | 53.5% | 948.15 | EUR 9.12M | EUR 7.68K | EUR 76.48M |
| FY2024 | EUR 40.46M | EUR 7.15M | n/a | 43.1% | 1418.41 | EUR 17.58M | EUR 328.52K | EUR 71.74M |
| FY2023 | EUR 44.07M | EUR 7.64M | n/a | 45.9% | 1514.43 | EUR 8.63M | EUR 3.44K | EUR 64.61M |
| FY2022 | EUR 47.63M | EUR 11.52M | n/a | 49.6% | 2284.78 | EUR 12.81M | EUR 4.83K | EUR 56.93M |
| FY2021 | EUR 41.62M | EUR 9.84M | n/a | 50.0% | 1951.38 | EUR 1.30M | EUR 18.89K | EUR 45.38M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-07 | EUR 91.30M | 11.8 | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 EUR.
About Eurofins-Cerep SA
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Eurofins-Cerep SA's market cap?
Eurofins-Cerep SA's market capitalization is EUR 91.30M.
What is Eurofins-Cerep SA's P/E ratio?
Eurofins-Cerep SA's price-to-earnings (P/E) ratio is 11.8.
What does Eurofins-Cerep SA do?
Eurofins-Cerep SA provides various drug discovery services to pharmaceutical, biopharmaceutical, and biotechnology companies France and internationally. The company also provides research services, including compound management, and high-throughout screening and profiling. The company was formerly known as Cerep SA and changed its name to Eurofins-Cerep SA in June 2014. Eurofins-Cerep SA was founded in 1989 and is based in Celle-Lévescault, France. Eurofins-Cerep SA is a subsidiary of Eurofins Discovery Services LUX Holding SARL.